Navigation Links
Molecular nano-spies to make light work of disease detection
Date:1/14/2014

A world of cloak-and-dagger pharmaceuticals has come a step closer with the development of stealth compounds programmed to spring into action when they receive the signal.

Researchers at the University of Nottingham's School of Pharmacy have designed and tested large molecular complexes that will reveal their true identity only when they've reached their intended target, like disguised saboteurs working deep behind enemy lines.

The compounds have been developed as part of a five-year programme funded by the Engineering and Physical Sciences Research Council (EPSRC) called "Bar-Coded Materials".

The cloak each spherical complex wears is perhaps more a plastic mac: a sheath of biocompatible polymer that encapsulates and shrouds biologically active material inside, preventing any biological interaction so long as the shield remains in place.

The smart aspect is in the DNA-based zips that hold the coat in place until triggered to undo. Because any DNA code (or "molecular cipher") can be chosen, the release mechanism can be bar-coded so that it is triggered by a specific biomarker for example a message from a disease gene.

What is then exposed an active pharmaceutical compound, a molecular tag to attach to diseased tissue, or a molecular beacon to signal activation depends on what function is needed.

Professor Cameron Alexander, who leads the project, says: "These types of switchable nanoparticles could be extremely versatile. As well as initial detection of a medical condition, they could be used to monitor the progress of diseases and courses of treatment, or adapted to deliver potent drugs at particular locations in a patient's body. It might even become possible to use mobile phones rather than medical scanners to detect programmed responses from later generations of the devices."

In their initial trials, the team has proved the concept works in the test tube the switchable molecular constructs do respond as expected when presented with the right molecular signals. The group is now working hard to push their idea forwards.

An early application might be in dipstick technology testing for specific infections in a blood or spit sample, for example. But because the polymer coating (called polyethylene glycol) is biocompatible, the researchers are hopeful that in the long run "self-authenticating medicines" based on the approach could be injected into patients, to seek out diseased tissue, and report their success.

"The key to this breakthrough has been the five-year EPSRC Leadership Fellowship awarded to me back in 2009", Professor Alexander comments. "This has provided the stability of funding to recruit and retain an outstanding team, who have been integral to realising the ideas put forward in the Fellowship. It has also given us the freedom to explore a whole range of new concepts, as well as the time needed to test our ideas to bring this and other breakthroughs within reach".


'/>"/>

Contact: EPSRC Press Office
pressoffice@epsrc.ac.uk
01-793-444-404
Engineering and Physical Sciences Research Council
Source:Eurekalert

Related medicine news :

1. Research shows molecular, protein targeting therapies may be best treatment for certain lung cancer
2. Molecular Diagnostics Role in Cancer Testing Analyzed in In-demand TriMark Report Published at MarketPublishers.com
3. New molecular targets identified in some hard-to-treat melanomas provide potential treatment option
4. The Association for Molecular Pathology releases position statement on LDTs
5. Polymer coatings based on molecular structures
6. Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior
7. Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis
8. Maryville, Tennessee based Molecular Pathology Laboratory Network, Inc. (MPLN) Acquires the First FDA Approved High-Throughput DNA Sequencing Analyzer
9. Treatment plans for brain metastases more accurately determined with aid of molecular imaging trace
10. ATCC Examined the Importance of High-quality Controls in Assay Design and Development During the Association for Molecular Pathology (AMP) 2013 Annual Meeting
11. BCC Research Publishes A New Report On Global Markets For Molecular Imaging Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: